250 (PB238): In Vivo Pharmacokinetics, Pharmacodynamics and Anti-tumour Efficacy of EXS74539: A Novel, Reversible LSD1 Inhibitor for Acute Myeloid Leukaemia
Title:
250 (PB238): In Vivo Pharmacokinetics, Pharmacodynamics and Anti-tumour Efficacy of EXS74539: A Novel, Reversible LSD1 Inhibitor for Acute Myeloid Leukaemia
Author:
Okumura, R. Thatikonda, V. Lautizi, M. Hieger, N. Senekowitsch, M. Lin, T.Y. Fiume, G. Winkler-Penz, T. Payne, A. Wilde, T. Dominguez, M. Müllers, E. Boudesco, C. Krall, N.